TABLE 1.
Baseline characteristics of the patients
| Variables | All (n = 121) |
|---|---|
| Age, years | 63 (57–71) |
| Male | 100 (82.6) |
| ECOG PS | |
| 0 | 36 (29.8) |
| 1 | 81 (66.9) |
| 2 | 4 (3.3) |
| Etiology | |
| HBV | 83 (68.6) |
| HCV | 7 (5.8) |
| Alcohol | 19 (15.7) |
| Others | 12 (9.9) |
| BCLC stage | |
| B | 20 (16.5) |
| C | 101 (83.5) |
| Child‐Pugh Class | |
| A | 109 (90.0) |
| B | 12 (10.0) |
| ALBI grade | |
| 1 | 67 (55.4) |
| 2 | 54 (44.6) |
| Number of intrahepatic tumors | |
| 0 | 15 (12.4) |
| 1 | 28 (23.1) |
| 2 | 29 (24.0) |
| 3 | 8 (6.6) |
| >3 | 41 (33.9) |
| Maximal size of intrahepatic tumor, cm | 4.8 (1.8–9.4) |
| Extrahepatic metastasis | 68 (56.2) |
| Macrovascular invasion | 50 (41.3) |
| AFP, ng/ml | 96 (7–1964) |
| DCP, mAU/ml | 186 (35–4084) |
| Neutrophil to lymphocyte ratio | 2.5 (1.8–4.0) |
| Platelet to lymphocyte ratio | 122.9 (87.1–180.7) |
| Lymphocyte to monocyte ratio | 1.5 (1.5–2.2) |
| Previous treatment | |
| Surgery | 33 (27.3) |
| Transarterial therapy | 67 (55.4) |
| Radioablation therapy | 10 (8.3) |
| Radiation therapy | 26 (21.5) |
| Presence of varices | 37 (30.6) |
| Treated varices at baseline | 22 (18.2) |
Note: Variables were presented as n (%) or median (IQR).
Abbreviations: AFP, alpha‐fetoprotein; ALBI, albumin‐bilirubin; BCLC, Barcelona clinic liver cancer; DCP, des‐gamma‐carboxy prothrombin; ECOG PS, European Cooperative Oncology Group performance status; HBV, hepatitis B virus; HCV, hepatitis C virus.